If you developed a chronic illness and an associated disability during your studies... where do you turn? How do you confront the challenge?
Cracking the mysteries of Alzheimer’s disease
With Pfizer shutting down its neuroscience unit and a long list of failed late-stage trials, the sheer difficulty of improving the treatment of Alzheimer’s disease has become painfully clear. How can researchers crack the mystery of this much-feared neurodegenerative disease?










